Area of research
Hematology · Public Health, Environmental and Occupational Health
Research interest
Research interests include Multiple Myeloma Research and Treatments, Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia Research, and Acute Lymphoblastic Leukemia research.
High dose total marrow irradiation (<scp>TMI</scp>) does not increase long‐term toxicity of myeloablative fludarabine/busulfan (<scp>FluBu4</scp>) conditioning regimen in allogeneic hematopoietic stem cell transplantation (<scp>HSCT</scp>)
Hematopoietic Stem Cell Transplantation in Nepal: International Partnership, Implementation Steps, and Clinical Outcomes
Updated Analyses: Safety and Efficacy of Gemtuzumab Ozogamicin and Venetoclax in Patients with Relapsed or Refractory CD33+ Acute Myeloid Leukemia: A Phase Ib/II Study
PI-RADS score is associated with biochemical control and distant metastasis in men with intermediate-risk and high-risk prostate cancer treated with radiation therapy
Improved health care utilization and costs in transplanted versus non-transplanted adults with sickle cell disease
The evolving role of translocation t(11;14) in the biology, prognosis, and management of multiple myeloma
Polypharmacy and potentially inappropriate medication use is highly prevalent in multiple myeloma patients and is improved by a collaborative physician–pharmacist clinic
Depressive symptoms, mental health-related quality of life, and survival among older patients with multiple myeloma
Synergistic Cytotoxic Effect of Busulfan and the PARP Inhibitor Veliparib in Myeloproliferative Neoplasms
Combined immune score of lymphocyte to monocyte ratio and immunoglobulin levels predicts treatment-free survival of multiple myeloma patients after autologous stem cell transplant
Bevacizumab Use and the Risk of Arterial and Venous Thromboembolism in Patients with High‐Grade Gliomas: A Nested Case‐Control Study
Haploidentical Peripheral Blood Stem Cell Transplantation Demonstrates Stable Engraftment in Adults with Sickle Cell Disease
Tumor necrosis factor‐alpha inhibitors and risk of non‐Hodgkin lymphoma in a cohort of adults with rheumatologic conditions
Collaborative Physician-Pharmacist–Managed Multiple Myeloma Clinic Improves Guideline Adherence and Prevents Treatment Delays
Myelodysplastic syndrome and acute myeloid leukemia after receipt of granulocyte colony‐stimulating factors in older patients with non‐Hodgkin lymphoma
A phase 1 trial of autologous stem cell transplantation conditioned with melphalan 200 mg/m<sup>2</sup>and total marrow irradiation (TMI) in patients with relapsed/refractory multiple myeloma
A prospective study of intravenous pentamidine for PJP prophylaxis in adult patients undergoing intensive chemotherapy or hematopoietic stem cell transplant
Strength Training to Enhance Early Recovery after Hematopoietic Stem Cell Transplantation
Melphalan 200 mg/m2 in patients with renal impairment is associated with increased short-term toxicity but improved response and longer treatment-free survival
Outcome Disparities in Caucasian and Non-Caucasian Patients With Myeloproliferative Neoplasms
Nonmyeloablative Stem Cell Transplantation with Alemtuzumab/Low-Dose Irradiation to Cure and Improve the Quality of Life of Adults with Sickle Cell Disease
Combination of Linear Accelerator–Based Intensity-Modulated Total Marrow Irradiation and Myeloablative Fludarabine/Busulfan: A Phase I Study